Davi S. Scomparin
3900 Bandeirantes Ave
Ribeirao Preto, SP, Brazil
Ribeirao Preto, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Comparative Analysis of Cannabidiol and Risperidone on Behavioral and Neurochemical Outcomes, and Neurodevelopment Markers in a Zebrafish Model of Embryonic Exposure to Sodium Valproate.
Journal: Autism research : official journal of the International Society for Autism Research
Published: May 20, 2025
Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19.
Journal: Brain, behavior, & immunity - health
Published: January 23, 2024
Anxiogenic doses of rapamycin prevent URB597-induced anti-stress effects in socially defeated mice.
Journal: Neuroscience letters
Published: August 04, 2023
Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic.
Journal: Frontiers in pharmacology
Published: January 17, 2022
Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Journal: Cannabis and cannabinoid research
Published: October 07, 2021
Genetic Ablation of the Inducible Form of Nitric Oxide in Male Mice Disrupts Immature Neuron Survival in the Adult Dentate Gyrus.
Journal: Frontiers in immunology
Published: September 24, 2021
Zebrafish as a Translational Model: An Experimental Alternative to Study the Mechanisms Involved in Anosmia and Possible Neurodegenerative Aspects of COVID-19?
Journal: eNeuro
Published: January 21, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026